ASGCT 2026: AI-Optimized Cas12l Gene Editor Offers Compact Cas9 Alternative

The CEO of Caszyme, a biotech company in Vilnius, Lithuania, presented details of Cas12l, a novel compact Cas nuclease with a variety of potential research and therapeutic applications. The post ASGCT 2026: AI-Optimized Cas12l Gene Editor Offers Compact Cas9 Alternative appeared first on GEN - Genetic Engineering and Biotechnology News .